Skip Navigation LinksHome > June 2014 - Volume 9 - Issue 6 > Contributor Index

June 2014 - Volume 9 - Issue 6 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 12 Next
Author Name Article
Aasebø, Ulf MD, PhD

Poor Prognosis Patients with Inoperable Locally Advanced NSCLC and Large Tumors Benefit from Palliative Chemoradiotherapy: A Subset Analysis from a Randomized Clinical Phase III...

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Amann, Joseph M. PhD

LKB1 Loss Induces Characteristic Patterns of Gene Expression in Human Tumors Associated with NRF2 Activation and Attenuation of PI3K-AKT

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Arasada, Rajeswara Rao PhD

LKB1 Loss Induces Characteristic Patterns of Gene Expression in Human Tumors Associated with NRF2 Activation and Attenuation of PI3K-AKT

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Archer, Venice MD

A Correlative Biomarker Analysis of the Combination of Bevacizumab and Carboplatin-Based Chemotherapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: Results of the Phase II...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Arriola, Edurne MD, PhD

A Complex Deletion/Insertion on Exon 19 of the EGFR Gene Predicts Response to Gefitinib

Purchase Access
Online Only
PDF
+ Favorites
Request Permissions
Asami, Kazuhiro MD

A Case of Large-Cell Neuroendocrine Carcinoma Harboring an EML4–ALK Rearrangement with Resistance to the ALK Inhibitor Crizotinib

Purchase Access
Online Only
PDF
+ Favorites
Request Permissions
Asamura, Hisao

Supplementary Prognostic Variables for Pleural Mesothelioma: A Report from the IASLC Staging Committee

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Atagi, Shinji MD

A Case of Large-Cell Neuroendocrine Carcinoma Harboring an EML4–ALK Rearrangement with Resistance to the ALK Inhibitor Crizotinib

Purchase Access
Online Only
PDF
+ Favorites
Request Permissions
Atallah, Soha MD

Stereotactic Body Radiotherapy in Patients with Previous Pneumonectomy: Safety and Efficacy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Beer, David G. PhD

TGM2: A Cell Surface Marker in Esophageal Adenocarcinomas

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Belinsky, Steven A. PhD

GATA2 is Epigenetically Repressed in Human and Mouse Lung Tumors and Is Not Requisite for Survival of KRAS Mutant Lung Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Berger, Michael F. PhD

Small-Cell Lung Cancers in Patients Who Never Smoked Cigarettes

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bezjak, Andrea MD

Stereotactic Body Radiotherapy in Patients with Previous Pneumonectomy: Safety and Efficacy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Brade, Anthony MD

Stereotactic Body Radiotherapy in Patients with Previous Pneumonectomy: Safety and Efficacy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bremnes, Roy M. MD, PhD

Poor Prognosis Patients with Inoperable Locally Advanced NSCLC and Large Tumors Benefit from Palliative Chemoradiotherapy: A Subset Analysis from a Randomized Clinical Phase III...

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Brock, Malcolm V. MD

Prospective CT Screening for Lung Cancer in a High-Risk Population: HIV-Positive Smokers

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Brown, Robert H. MD

Prospective CT Screening for Lung Cancer in a High-Risk Population: HIV-Positive Smokers

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Brown, Travis MS

Prospective CT Screening for Lung Cancer in a High-Risk Population: HIV-Positive Smokers

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Burdaeva, Olga MD

A Correlative Biomarker Analysis of the Combination of Bevacizumab and Carboplatin-Based Chemotherapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: Results of the Phase II...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cai, Weijing MD, PhD

Coexistence of Three Variants Involving Two Different Fusion Partners of ROS1 Including a Novel Variant of ROS1 Fusions in Lung Adenocarcinoma: A Case Report

Purchase Access
Online Only
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 12 Next